ABSTRACT-The effects of tiropramide hydrochloride on Ca 2+ induced contraction, cytoplasmic free Ca 2+ levels and tissue cyclic AMP concentrations were investigated to elucidate the mechanisms of its antispasmodic action in the isolated detrusor from rats. Tiropramide inhibited the Ca 2+ (3 mM) induced contractions of the isolated urinary bladder depolarized in a Ca2+free medium, and the IC50 value was 3.3 X 10-6 M. When tiropramide was added during the sustained phase of the K+ (60 mM) contracture, IC50 values of tiropramide for the contraction and the increased fluorescence were 1.9 X 10-5 M and 16.4 X 10-5 M, respectively. On the other hand, the IC50 values for the K=induced con traction and fluorescence after pretreatment of the isolated urinary bladder with tiropramide were 2.1 X 10-5 M and 2.6 X 10-5 M, respectively. Tissue cyclic AMP levels at 1 min after addition of 10-5 M tiropramide were significantly increased. Papaverine, IBMX or forskolin potentiated the inhibitory effect of tiropramide on carbachol-induced contraction and its cyclic AMP-elevating effect. However, a good correlation between the degrees of potentiation of the inhibitory effect and the increase in cyclic AMP levels was not observed. The present results suggest that the smooth muscle relaxant activity of tiropramide in the isolated detrusor from rats may be intimately associated with predominant inhibition of Ca2+ influx and, to a lesser extent, an increase in intracellular cyclic AMP levels.
Tiropramide hydrochloride, (±) a -benzoylamino-(2 diethylamino-ethoxy)-N, N dipropylbenzenepropanamide hydrochloride is pharmacologically characterized as a broad spectrum antispasmodic (1) (2) (3) . Several mecha nisms have been proposed to explain its action includ ing a rise of tissue cyclic AMP levels by inhibition of phosphodiesterase and a subsequent increase in uptake of Ca 2+ into the sarcoplasmic reticulum (4) and the in hibition of Ca 2+ influx into the smooth muscle cell (1) . There is, however, little information on the precise mechanisms of tiropramide in the isolated urinary blad der of rats. Therefore, we investigated the effects of tiropramide on the isolated detrusor from rats, with particular emphasis on simultaneous recordings of K+ induced contraction and change in intracellular fura-2 fluorescence, and intracellular cyclic AMP levels. The effects of tiropramide on Ca2 ± induced contraction and those of a combination of tiropramide and cyclic AMP elevating agents on carbachol-induced contraction and tissue cyclic AMP levels were also studied.
MATERIALS AND METHODS

Measurement of muscle tension
Male Wistar rats (7 9 weeks old) were killed by stunning and bleeding. The bladder dome was excised immediately, carefully dissected free from visible con nective tissue and cut longitudinally into two strips (2 mm wide and 8 mm long). The strip was vertically sus pended under a resting load of 1 g in a 10-m1 organ bath filled with Krebs-Henseleit solution continuously gassed with a mixture of 95% 02 and 5% CO2 and maintained at 37°C, and connected for recording of isometric contraction to a displacement transducer (UL 10GR, Minebea Co., Ltd., Nagano). The physiological solution had the following composition: 118 mM NaCl, 4.7 mM KC1, 2.5 mM CaC12, 1.2 mM MgSO4, 25 mM NaHCO3, 1.2 mM KH2PO4, and 11.0 mM glucose. Af ter an equilibration period of 60 min, experiments were performed.
For the experiments of the combined effects of tiro pramide with papaverine or forskolin, concentration response curves for carbachol were constructed in a cumulative manner in the absence and presence of tiropramide, papaverine, forskolin, tiropramide plus papaverine, or tiropramide plus forskolin. The antispas modics were preincubated for 5 min. The concentra tions used were 1.5 X 10-5 M for tiropramide, 3 X 106 M for papaverine, and 106 M for forskolin; These concentrations corresponded to the IC30 for tiropramide and the IC10s for papaverine and forskolin. All responses are expressed as a percentage of the max imal increase in tension induced by carbachol in the absence of the antispasmodics. For the study of Ca 2 induced contraction, after an equilibration period of 60 min in Krebs-Henseleit solu tion, the isolated urinary bladder strip was washed twice every 5 min in CaC12-depleted Krebs-Henseleit solution. The solution was then changed to the Ca2 free, depolarizing solution, which was obtained by re placing 118 mM NaCI by an equimolar amount of KCI. Ten minutes after that procedure, concentration response curves for CaC12 were constructed in a cumulative manner. Tiropramide and terodiline were preincubated 5 min before the addition of CaC12.
Measurement of changes in cytosolic Ca2+ by fura-2 Cytoplasmic Ca 2+ levels were measured using the Ca 2+ sensitive fluorescent dye fura-2. For this experi ment, the urinary bladder dome was excised and cut longitudinally into four segments (2 mm wide and 7 mm long). The mucous membrane of the segments was re moved. The segments were treated with the fura-2/AM at 5 X 10-6 M for 3 hr at room temperature in a darken ed room. The fura-2 loading solution contained 136.9 mM NaCI, 5.4 mM KCI, 1.5 mM CaC12, 1.0 mM MgC12, 23.8 mM HEPES, 5.5 mM glucose, 0.02% cre mophore EL (BASF Japan) and 10,uM N,N,N',N' tetrakis (2-pyridilmethyl)ethylenediamine (TPEN, Dojin, Kumamoto) (pH 7.4) (5).
After the fura-2 loading, the strip was spread out and fixed to a holder to minimize contractile movement. One end of the muscle strip was connected to a strain gauge transducer. Fluorescence measurements were car ried out in a CAF-100 instrument (Jasco Co., Tokyo) equipped with a specially designed tissue bath (7 ml). Fura-2 fluorescence was measured at 340 and 380 nm (excitation) and 500 nm (emission), and the time course of the fluorescence change in the 380/340 nm ratio and the isometric muscle contraction (load: 1 g) were re corded simultaneously. The tissue was superfused with a physiological salt solution, equilibrated with 95% 02 and 5% CO2 and warmed (37°C), by means of a peri staltic pump at a flow rate of 7 ml/min. The salt solu tion had the following composition: 136.9 mM NaCl, 5.4 mM KCI, 1.5 mM CaC12, 1.0 mM MgC12, 23.8 mM NaHCO3, and 5.5 mM glucose (pH 7.4). After a 20 to 40-min superfusion period, the responses of the detru sor to drugs were determined. The superfusion was in terrupted 5 min before the determination and drugs were added in the tissue bath, bubbled with a mixture of 95% 02 and 5% CO2. The smooth muscle relaxants, tiropramide, terodiline and diltiazem, were introduced 5 min before or 5 to 10 min after 60 mM K+ addition (hypertonic). The relaxant concentrations (IC50) that halved the contractile response to 60 mM K+ were calculated.
Determination of cyclic AMP content
Male Wistar rats (15 weeks old) were used. The blad der dome was cut longitudinally into four parts of 2 X 8 mm. The segments were equilibrated for 1 hr at 37°C in oxygenated Krebs-Henseleit solution. After incubation with the normal or drug-containing physiological salt solutions for 1, 3, or 10 min, the muscles were plunged into liquid nitrogen. The frozen tissues were then homogenized in cold 6% trichloroacetic acid (2 ml) at 4°C, and centrifuged at 2,000 X g for 10 min. Super natants were recovered and washed 5 times with 5 volumes of water saturated diethylether. The aqueous extracts remaining were lyophilized, the dried extracts were dissolved in assay buffer, and cyclic AMP was then assayed using Amersham's cAMP[ 125I]assay system (dual range). Protein content was determined by the Lowry method (6) with bovine serum albumin as a standard.
Statistical analyses
All numerical data are expressed as the mean ± S.E. Tests of significance were performed by Student's t-test. A P value of less than 0.05 was considered to indicate a significant difference.
Drugs and chemicals
Tiropramide hydrochloride and terodiline hydro chloride were supplied by SmithKline Beecham Phar maceuticals, Tokyo. Forskolin, 3-isobutyl-l-methylxan thine (IBMX), diltiazem hydrochloride and papaverine hydrochloride were obtained from Sigma Chemical Co., St. Louis, MO, and carbamylcholine chloride (car bachol) was from Tokyo Kasei, Tokyo. All drugs were dissolved in deionized water or a physiological salt solu tion (fluorescence measurement) except for forskolin. Forskolin was dissolved in ethanol and its final concen tration in the bathing solution never exceeded 0.4% (v/v). This concentration of ethanol little affected the carbachol-induced contraction of the isolated urinary bladder from rats and the control experiments were performed in the presence of an equal concentration of ethanol. 
RESULTS
Combined effects of tiropramide with papaverine or fors kolin Figure 1 illustrates the inhibitory effect of tiropra mide on the concentration-response curves for carba chol in the absence and presence of the cyclic AMP elevating agents, papaverine and forskolin, in the iso lated detrusor of rats. Tiropramide at a concentration of 1.5 X 10-5 M shifted the concentration-response curve downward, and papaverine (3 X 10-6 M) had lit tle effect on the curve for lower concentrations of car bachol (Fig. IA) . A combination of tiropramide and papaverine potentiated the inhibitory effect of tiropra mide on the contraction induced by carbachol (3 X 10-6 to 10-4 M). Forskolin at a concentration of 10-6 M displaced the concentration-response curve for car bachol to the right. Forskolin enhanced the relaxing effect of tiropramide at all concentrations of carbachol used.
Effects of tiropramide on Cat -induced contraction
The effects of tiropramide and terodiline on cumula tive concentration-response curves for CaCl2 in the K± depolarized urinary bladder of rats are shown in Fig. 2 . Contractions of the isolated urinary bladder by CaC12 in the Cat+free, isotonic high K+ medium were dose dependently inhibited by tiropramide (3 X 10-6 M and 6 X 10-6 M), and terodiline (3 X 10-6 M, 10-5 M) in hibited dose-dependently Cat±induced contractions (Fig. 2) . IC50 values (X 10-6 M) of tiropramide and terodiline for the Ca 2+ (3 mM)-evoked contractions were 3.3 ± 0.2 (N = 5) and 5.8 ± 0.5 (N = 6), respec tively, and there was a significant difference between the two values (P < 0.05).
Effect of tiropramide on changes in [Ca2+]
The effects of tiropramide on high K+ (60 mM) induced fluorescence and contractions measured simul taneously in the same detrusor from the rat are de picted in Fig. 3 . Addition of hypertonic K+ (60 mM) caused rises of the fluorescence and force development. After reaching their peak values, they declined and reached steady state levels (Fig. 3) . The fluorescence increment preceded the force development. On washing out the K=rich medium, both fluorescence and force returned to their control values (data not shown). Tiropramide inhibited the increased fluorescence and contracture induced by the high K+, independent of the pre or post-treatment of the tissue with tiropramide (Fig. 3, A and B) . Table I summarizes IC50 values for tiropramide, tero diline and diltiazem when the smooth muscle relaxants were introduced 5 min before (pre-treatment) or 5 to 10 min after (post-treatment) the addition of 60 mM K When tiropramide or terodiline was added during the sustained phase of the K+contracture, the IC50 values for tiropramide to the contraction and the increased fluorescence were 1.9 X 10-5 M and 16.4 X 10-5 M, respectively, and the respective IC50 values for terodi line were 0.6 X 105 M and 1.0 X 10-5 M ( Table 1) . The increased fluorescence was resistant to tiropramide to a greater extent as compared with the contraction (P < 0.05). On the other hand, the K+-induced contrac tion and fluorescence after pretreatment of a urinary bladder strip with tiropramide were inhibited to the same extent, and no significant difference was observed between the IC50 values. The results obtained with terodiline and diltiazem were similar to those obtained with tiropramide, although diltiazem was more potent (Table 1) .
Effect of tiropramide on tissue cyclic AMP levels
The effects of tiropramide (10- 
DISCUSSION
In the present study, tiropramide and terodiline inhib ited the contractile response to Ca 2+ in K±depolarized rat urinary bladder, suggesting that the possibility that their relaxation effect on the smooth muscle may be re lated to an inhibition of Ca 2+ entry into the cell. Simi lar results have been obtained by Takayanagi et al. (1) in K±depolarized guinea pig taenia caecum. However, it has been reported (2) that tiropramide shows very small calcium channel blocking activity in vascular smooth muscles. These results indicate the different effects of tiropramide on the Ca 2+ channels in different smooth muscles. The calcium antagonistic effects of terodiline have been demonstrated in several in vitro models (7) (8) (9) . Our results suggest that the inhibitory effect of tiropramide on Ca 2+ induced contractions is more potent than that of terodiline in the isolated de trusor from rats.
The observations described above illustrate the use fulness of the Ca 2-1 indicator fura-2 for investigating the mechanisms of action of tiropramide in the urinary bladder of rats. Increases in fluorescence and force in duced by K+ depolarization were reduced by tiropra mide. A good correlation between reductions of fluorescence and contraction was obtained when the rat urinary bladder was pretreated with tiropramide. Simi lar results were obtained with diltiazem, a calcium an tagonist. When tiropramide was added during the sus tained phase of the K+contraction, the fluorescence was reduced to a less extent compared to the contrac tion. On the other hand, the inhibitory effects of tero diline on the fluorescence and contraction were similar, independent of whether the tissue was pretreated or post-treated with terodiline. These results suggest that tiropramide predominantly inhibit Ca 2+ entry into the cell via voltage-dependent Ca 2+ channels in the urinary bladder of rats.
Vidal y Plana et al. (4) have suggested that the smooth muscle relaxant activity of tiropramide in the isolated rabbit colon arises from the drug-induced in crease in tissue cyclic AMP concentrations possibly be cause of an inhibition of cyclic AMP catabolism. If the antispasmodic effect of tiropramide is closely linked to cyclic AMP-generation, a combination of low concent rations of a phosphodiesterase inhibitor or an adenyl ate cyclase activator with tiropramide should result in a great potentiation of the relaxing response to tiropra mide. We investigated the combined effects of tiropra mide with papaverine, a phosphodiesterase inhibitor, or forskolin, an adenylate cyclase activator, on contractile responses in the rat isolated detrusor. The effect of the combination of tiropramide and papaverine on the concentration-response curve for carbachol was com plex, and the curve was shifted downward at higher concentrations of carbachol. In contrast, forskolin en hanced the relaxing effect of tiropramide at all concen trations of carbachol used. These results suggest that the effect of tiropramide is differently influenced by the phosphodiesterase inhibitor and the adenylate cyclase activator. The cyclic AMP-increasing effect of tiropra mide was also potentiated by IBMX or forskolin. Thus, the present data on the combined effects of the phospo diesterase inhibitors or forskolin with tiropramide on mechanical responses or intracellular cyclic AMP levels were so confusing that it was not possible to predict the precise mechanisms of the cyclic AMP-elevating action of tiropramide. The complex effects of a combination of tiropramide and papaverine may be due to multiple possible mechanisms of action of papaverine, such as phosphodiesterase inhibition (10, 11) , inhibition of Ca 2+ influx (12, 13) and Ca 2+ release (13) . It has reported that the effects of a combination of tiropramide and theophylline on cyclic AMP concentrations are additive and that tiropramide produced a dose-dependent inhibi tion of phosphodiesterase activity in the rabbit colon only at concentrations higher than those causing muscle relaxation (4) . In the present study, tiropramide at a concentration of 105 M, which causes muscle relaxa tion, produced increases in the cyclic AMP levels (IC50 of tiropramide for carbachol-induced contraction = 3.6 X 10-5 M) (14) . Our results and those of others sug gest that the antispasmodic effects of tiropramide are, in part, related to increased intracellular cyclic AMP levels by an inhibition of phosphodiesterase activity.
Forskolin elevated cyclic AMP levels to a great ex tent at a concentration lower than that producing mus cle relaxation. It would appear that a direct correlation between the amount of cyclic AMP produced and mag nitude of the inhibitory response may not always be observed when comparing the response to papaverine. A possible explanation for this might be that forskolin could activate most, if not all, of the adenylate cyclase. Vegesna and Diamond (15) have suggested some form of functional compartmentalization of cyclic AMP in smooth muscle.
In conclusion, our results suggest that the smooth muscle relaxant activity of tiropramide in the isolated detrusor from rats is intimately associated with the pre dominant inhibition of Ca 2+ influx and, to a lesser ex tent, the increase in intracellular cyclic AMP levels.
